Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Analyst|December 11, 2013
reMelting curve analysis as a tool for enrichment monitoring in the SELEX processJeroen Vanbrabant, Karen Leirs, Katrijn Vanschoenbeek, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 4, 2014
Aptamers targeting different functional groups of 17β-estradiolKatrijn Vanschoenbeek, Jeroen Vanbrabant, Baharak Hosseinkhani, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 26, 2023
Cancer Registration, Molecular Marker Status, and Adherence to the WHO 2016 Classification of Pathology Reports for Glioma Diagnosed during 2017-2019 in BelgiumDimitri Vanhauwaert, Harry Pinson, Katrijn Vanschoenbeek, et al.
Biosensors|July 12, 2016
Enhanced Biosensor Platforms for Detecting the Atherosclerotic Biomarker VCAM1 Based on Bioconjugation with Uniformly Oriented VCAM1-Targeting NanobodiesDuy Tien Ta, Wanda Guedens, Tom Vranken, et al.
Patient Preference and Adherence|September 30, 2024
Imatinib Adherence and Persistence in Patients with Chronic Myeloid Leukemia in Belgium: Evidence from Real-World DataSandra Michiels, Sandra Tricas-Sauras, Adriano Salaroli, et al.
Frontiers in Epidemiology|March 8, 2024
Patterns of care and survival for lung cancer: Results of the European population-based high-resolution studyMilena Sant, Caterina Daidone, Kaire Innos, et al.
Neuro-Oncology|August 31, 2023
Epidemiology and survival of adult-type diffuse glioma in Belgium during the molecular eraHarry Pinson, Geert Silversmit, Dimitri Vanhauwaert, et al.
Cancer Medicine|October 30, 2024
Measuring the diagnostic management and follow-up imaging for glioma patients across Belgian hospitals between 2016 and 2019Dimitri Vanhauwaert, Katrijn Vanschoenbeek, Frank Weyns, et al.
Journal of Neuro-Oncology|August 2, 2024
Association of hospital volume with survival but not with postoperative mortality in glioblastoma patients in BelgiumDimitri Vanhauwaert, Geert Silversmit, Katrijn Vanschoenbeek, et al.
Oral Oncology|January 10, 2020
Comorbidity in head and neck cancer: Is it associated with therapeutic delay, post-treatment mortality and survival in a population-based study?Sabine Stordeur, Viki Schillemans, Isabelle Savoye, et al.
Pageof 2